Fosbøl, E. L., Butt, J. H., Østergaard, L., Andersson, C., Selmer, C., Kragholm, K., . . . Køber, L. (2020). Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality. JAMA : the journal of the American Medical Association, 324(2), 168. https://doi.org/10.1001/jama.2020.11301
Citácia podle Chicago (17th ed.)Fosbøl, Emil L., et al. "Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality." JAMA : The Journal of the American Medical Association 324, no. 2 (2020): 168. https://doi.org/10.1001/jama.2020.11301.
Citácia podľa MLA (8th ed.)Fosbøl, Emil L., et al. "Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality." JAMA : The Journal of the American Medical Association, vol. 324, no. 2, 2020, p. 168, https://doi.org/10.1001/jama.2020.11301.